By vgreene, 17 June, 2015 Exclude Patient Type Detail Header No Detail Type Text Detail Text Written action plan based on sx or peak flow Educate sx meds inhaler technique environment control 6 comorbidity7 mgmt F U q2 6wk while gaining control q1 6mo to monitor control q3mo if step down tx anticipated Spirometry1 q1-2yrs (more frequently if not well controlled) May use FeNO as part of monitoring w hx clinical findings spirometry in pts w persistent allergic asthma Inactivated flu vaccine annually Patient Type Detail Header (Long) Offer action plan + pt ed, F/U in 2-6wk